Drug intelligence / Profile preview

compact RT editor

Development stage
Preclinical
Lead developer
Arbor Biotechnologies
Modality
CRISPR-Cas9 → CRISPR Systems → Programmable Nucleases → Gene Editing → Gene Therapies, Gene Silencing → Gene Therapies, Gene Addition/Replacement → Gene Therapies
Administration
Intravenous, Intracerebroventricular
01

Overview

The compact RT editor is a miniature genome editing system developed by Arbor Biotechnologies for precise DNA modification. It consists of a miniature nuclease containing RuvC and HNH domains (RHNs) engineered into a nickase and fused to a small, highly active reverse transcriptase (RT). With a total size of under 1200 amino acids, the entire editor and its guide RNA can be packaged into a single adeno-associated virus (AAV) vector, overcoming the packaging limits of first-generation prime editors. The system utilizes template-primed reverse transcription to introduce specific edits without requiring double-strand DNA breaks. It has demonstrated in vivo efficacy in mouse models, achieving significant precise editing in the liver and brain, and is being developed for neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS), Huntington’s Disease, and Alzheimer’s Disease.

Other names
all-in-one AAV compact RT editor
02

Targets

gDNA (Genomic DNA at programmable loci)

Beyond the preview

Go deeper on compact RT editor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compact RT editor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call